These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. Whitley RJ; Soong SJ; Dolin R; Betts R; Linnemann C; Alford CA N Engl J Med; 1982 Oct; 307(16):971-5. PubMed ID: 7110300 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of herpes zoster]. Revuz J; Huraux JM Ann Dermatol Venereol; 1983; 110(6-7):507-11. PubMed ID: 6638780 [TBL] [Abstract][Full Text] [Related]
11. Fatal vidarabine toxicity in a patient with normal renal function. Van Etta L; Brown J; Mastri A; Wilson T JAMA; 1981 Oct; 246(15):1703-5. PubMed ID: 7277649 [No Abstract] [Full Text] [Related]
12. Herpes zoster encephalitis: successful therapy with vidarabine. Wees SJ; Madhavan T Henry Ford Hosp Med J; 1980; 28(1):67-70. PubMed ID: 7287499 [No Abstract] [Full Text] [Related]
13. Managing herpes zoster in immunocompromised patients. Ahmed AM; Brantley JS; Madkan V; Mendoza N; Tyring SK Herpes; 2007 Sep; 14(2):32-6. PubMed ID: 17939900 [TBL] [Abstract][Full Text] [Related]
14. Disseminated herpes zoster and the syndrome of inappropriate antidiuretic hormone. White TM; Hoffman JH; Holmes WH; Huntley RG Conn Med; 1982 Jul; 46(7):373-4. PubMed ID: 7116837 [No Abstract] [Full Text] [Related]